BEACOPP regimen

View Patient Information

A regimen consisting of bleomycin, etoposide, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine and prednisone, used for the treatment of advanced-stage Hodgkin lymphoma.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	BEACOPP bleomycin-etoposide-Adriamycin-cyclophosphamide-Oncovin-procarbazine-prednisone regimen bleomycin/cyclophosphamide/doxorubicin/etoposide/prednisone/procarbazine/vincristine

BEACOPP regimen

Search NCI's Drug Dictionary